disease arises from asynchrony and abnormalities in the complex and coordinated electro-mechanical properties over time and space. Therefore, devices that allow monitoring and controlling of the spatiotemporal dynamics of cardiac activity are crucial for unraveling the pathophysiology of heart disease and developing effective treatment therapies in clinical cardiology practice. Implantable electronic pacemakers play an essential role in treating various types of arrhythmias and heart failure and studying cardiac physiology by changing the membrane potential and triggering an action potential with an electric current. [3,4] However, electrical stimulation can lead to adverse effects on cell health and integrity due to the cell membrane electroporation and redox processes. [5,6] The electrical fields created by the stimulation electrodes will generate electrical crosstalk between stimulation and recording electrodes and result in recording artifacts. [7] Furthermore, electrical stimulation is unable to target specific subtypes of cardiac cells. Optogenetics uses light to modulate the activity of genetically targeted cell types through photosensitive ion channels and pumps. [8] Despite its initial use in neuroscience research to control neural circuits, [8,9] optogenetics has now been applied as a promising tool in cardiology for pain-free, low-energy optical pacing, and defibrillation with cell-type specificity. [10][11][12] In addition, cardiac optogenetics generally interferes less with simultaneous electrical readout of cardiac activity compared to electrical stimulation. Currently, cardiac optogenetics is primarily used in in vitro and ex vivo cardiac studies with cell cultures or explanted perfused hearts. [13][14][15][16][17] More in vivo research is crucially needed to fully exploit the unique opportunities cardiac optogenetics offers for mechanistic investigations of heart function in health and disease.Small animal models such as mice and rats are the main rodent species that could be genetically engineered for in vivo cardiac optogenetics research and their heart electrophysiology is a good approximation of the human electrophysiology. [18] Implantable cardiac devices that combine precise light delivery to targeted heart regions of small animals with electrophysiological readout capabilities remain a major technological Bioelectronic devices that allow simultaneous accurate monitoring and control of the spatiotemporal patterns of cardiac activity provide an effective means to understand the mechanisms and optimize therapeutic strategies for heart disease. Optogenetics is a promising technology for cardiac research due to its advantages such as cell-type selectivity and high space-time resolution, but its efficacy is limited by the insufficient number of modulation channels and lack of simultaneous spatiotemporal mapping capabilities in current implantable cardiac optogenetics tools available for in vivo investigations. Here, soft implantable electro-optical cardiac devices integrating multilayered highly ...